Cargando…
CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis
OBJECTIVE: Growing evidence shows that enhancer RNAs (eRNAs) are pivotal for tumor progression. In this research, our team aimed to identify the survival-related eRNAs and further explore their potential function in glioblastoma (GBM). METHODS: RNA-sequencing data in 31 tumor types were acquired fro...
Autores principales: | Ye, Tao, Li, Lan-lan, Peng, Xue-mei, Li, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733712/ https://www.ncbi.nlm.nih.gov/pubmed/35003394 http://dx.doi.org/10.1155/2021/8565943 |
Ejemplares similares
-
Case Report: A combination of chimeric CYP11B2/CYP11B1 and a novel p.Val68Gly CYP11B1 variant causing 11β-Hydroxylase deficiency in a Chinese patient
por: Li, Jialin, et al.
Publicado: (2023) -
Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency
por: Xie, Hua, et al.
Publicado: (2022) -
Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: Three novel mutations in CYP1B1
por: Hilal, Latifa, et al.
Publicado: (2010) -
CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers
por: Yuan, Benchao, et al.
Publicado: (2022) -
Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
por: Al-saraireh, Yousef M., et al.
Publicado: (2021)